✦ LIBER ✦

Generating insulin-producing cells for diabetic therapy: Existing strategies and new development

✍ Scribed by Shen, Jing; Cheng, Yu; Han, Qingwang; Mu, Yiming; Han, Weidong

Book ID: 120331587
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 691 KB
Volume: 12
Category: Article
ISSN: 1872-9649
DOI: 10.1016/j.arr.2013.01.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strategies for differentiating embryonic

Strategies for differentiating embryonic stem cells (ESC) into insulin-producing cells and development of non-invasive imaging techniques using bioluminescence

✍ Kun-Ming Chan; Sudhanshu P. Raikwar; Nicholas Zavazava 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 275 KB

Combination therapy for preservation of

Combination therapy for preservation of beta cell function in Type 1 diabetes: New attitudes and strategies are needed!

✍ Ludvigsson, Johnny 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 822 KB

Generation of confluent cardiomyocyte mo

Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategies

✍ Zweigerdt, R.; Burg, M.; Willbold, E.; Abts, H.F.; Ruediger, M. 📂 Article 📅 2003 🏛 Informa plc 🌐 English ⚖ 464 KB

Double knockdown of α1,6-fucosyltransfer

Double knockdown of α1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC

✍ Harue Imai-Nishiya; Katsuhiro Mori; Miho Inoue; Masako Wakitani; Shigeru Iida; K 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 614 KB

## Background Antibody-dependent cellular cytotoxicity (ADCC) is greatly enhanced by the absence of the core fucose of oligosaccharides attached to the Fc, and is closely related to the clinical efficacy of anticancer activity in humans __in vivo__. Unfortunately, all licensed therapeutic antibodie

[RSC Drug Discovery] New Therapeutic Str

[RSC Drug Discovery] New Therapeutic Strategies for Type 2 Diabetes Volume 74 || Chapter 11. The Discovery and Development of MB07803, a Second-Generation Fructose-1,6-bisphosphatase Inhibitor with Improved Pharmacokinetic Properties, as a Potential Treatment of Type 2 Diabetes

✍ Jones, Rob M 📂 Article 📅 2012 🏛 Royal Society of Chemistry ⚖ 720 KB